Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, Inc. (SGNT) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 299 transactions totaling $123.2M, demonstrating a bearish sentiment with -$122.3M in net insider flow. The most recent transaction on Aug 29, 2016 involved a transaction of 742 shares valued at $16.1K.
SGNT Insider Activity Summary
Who Is Buying SGNT Stock?
No significant insider buying has been recorded for SGNT in the recent period.
Who Is Selling SGNT Stock?
No significant insider selling has been recorded for SGNT in the recent period.
Is Sagent Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SGNT is bearish with an Insider Alignment Score of 0/100 and a net flow of -$122.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SGNT Frequently Asked Questions
Understanding SGNT Insider Activity
Insider trading at Sagent Pharmaceuticals, Inc. (SGNT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading SGNT stock, having executed 299 transactions in the past 90 days. The most active insider is Ventures Fund V, L.p. Vivo (Executive), who has made 4 transactions totaling $77.0M.
Related Tools
Track Sagent Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at SGNT file new Form 4 transactions